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Hypertensive diseases of pregnancy and risk of
hypertension and stroke in later life: results from cohort
study
Brenda J Wilson, M Stuart Watson, Gordon J Prescott, Sarah Sunderland, Doris M Campbell,
Philip Hannaford, W Cairns S Smith
Abstract
Objective To examine the association between
hypertensive diseases of pregnancy (gestational
hypertension and pre-eclampsia) and the
development of circulatory diseases in later life.
Design Cohort study of women who had
pre-eclampsia during their first singleton pregnancy.
Two comparison groups were matched for age and
year of delivery, one with gestational hypertension
and one with no history of raised blood pressure.
Setting Maternity services in the Grampian region of
Scotland.
Participants Women selected from the Aberdeen
maternity and neonatal databank who were resident
in Aberdeen and who delivered a first, live singleton
from 1951 to 1970.
Main outcome measures Current vital and
cardiovascular health status ascertained through
postal questionnaire survey, clinical examination,
linkage to hospital discharge, and mortality data.
Results There were significant positive associations
between pre-eclampsia/eclampsia or gestational
hypertension and later hypertension in all measures.
The adjusted relative risks varied from 1.13-3.72 for
gestational hypertension and 1.40-3.98 for
pre-eclampsia or eclampsia. The adjusted incident
rate ratio for death from stroke for the
pre-eclampsia/eclampsia group was 3.59 (95%
confidence interval 1.04 to 12.4).
Conclusions Hypertensive diseases of pregnancy
seem to be associated in later life with diseases related
to hypertension. If greater awareness of this
association leads to earlier diagnosis and improved
management, there may be scope for reducing a
proportion of the morbidity and mortality from such
diseases.
Introduction
Cardiovascular disease is a major public health
problem in women in developed countries. Each year
in the United Kingdom over 150 000 women die from
vascular causes (mainly ischaemic heart disease and
stroke).1 Many die prematurely2 or experience a
non-fatal event, often leaving them with permanent
disability. In Britain angina may be as common in
women as in men.3 Most of the aetiological research in
women has concentrated on risk factors that are
shared by men—for example, smoking, social class,
family history, obesity, and lipid and clotting factors.
Women, however, are exposed to several possible risk
factors that are sex specific, including pregnancy,
menopause, hysterectomy, and the use of exogenous
hormones. Vital statistics collected in England and
Wales between 1938 and 1960 suggest that pregnancy
has an effect as parous women have higher mortality
from hypertension, ischaemic and degenerative heart
disease, and cerebrovascular disease than nulliparous
women.4
During pregnancy, many women are affected by
hypertensive problems, especially in the first preg-
nancy.5 Such problems fall into four categories: chronic
(pre-existing) hypertension, gestational (transient)
hypertension, pre-eclampsia/eclampsia, and pre-
eclampsia superimposed on chronic hypertension.6
While the exact prevalence of each condition is
difficult to determine, almost 10% of all pregnancies
are thought to be complicated by high blood pressure.5
Nearly 30% of first pregnancies are thought to be
affected by gestational hypertension, pre-eclampsia, or
eclampsia.6
Despite their frequent occurrence, relatively little
research has been conducted into the long term effects
of hypertensive problems in pregnancy. Both
gestational hypertension and pre-eclampsia or
eclampsia may be associated in later life with raised
blood pressure7–11 or hypertension12–15 and cardiovas-
cular disease.16 17 Many of the reported studies have
examined only hypertension as an outcome and have
been limited by small sample sizes,7 9–13 15 inappropriate
comparison groups,8 12 15 18 or relatively short follow
up.7 8 There is also evidence to suggest that self
reported exposure is more prone to recall bias with
increasing time.19–21 As information on pregnancy
related exposures is often sought more than 10 years
later20 22 recall bias is of particular concern.
We designed a retrospective cohort study using the
Aberdeen maternity and neonatal databank, a compu-
terised database which has collated validated data on
all obstetric events in women attending the Aberdeen
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maternity hospital since 1951.23 The hospital and asso-
ciated units provide obstetric care for a population of
about 400 000 people. The databank used standard-
ised diagnostic criteria during the study and linkage to
the individual original obstetric case notes. We
determined whether a recorded history of gestational
hypertension or pre-eclampsia or eclampsia predicted
cardiovascular disease in later life, as indicated by
measures of mortality and morbidity.
Methods
Identification and tracing of women
From the databank we identified a cohort of women
who were living in Aberdeen city at the time of delivery.
The cohort comprised all women who had a diagnosis
of pre-eclampsia or eclampsia during their first single-
ton pregnancy in the years 1951 to 1970; an individu-
ally matched sample of women with a diagnosis of
gestational hypertension during their first singleton
pregnancy and matched for age to the nearest year and
year of delivery with the previous group; and an
individually matched sample of women with no history
of raised blood pressure during their first singleton
pregnancy likewise matched with the first group.
Gestational hypertension was defined as diastolic pres-
sure ≥ 90 mm Hg on two occasions at least four hours
apart or a single reading of ≥ 110 mm Hg from 20
weeks’ gestation onwards in a previously normotensive
woman. Pre-eclampsia was defined as gestational
hypertension plus proteinuria of ≥ 0.3 g/24 hours.
Eclampsia was defined clinically as convulsions occur-
ring in the presence of pre-eclampsia. Women with
chronic hypertension were separately categorised on
the databank and excluded from this study. No other
exclusion criteria were applied.
We carried out two tracing exercises for the cohort.
The first, carried out in 1996, was at the local level
using the Grampian community health index (a
comprehensive regional primary care register24) to
identify the current name and address of all cohort
members still alive and resident in the Grampian area.
From this exercise we were able us to contact the cur-
rent general practitioners of women in the original
cohort who were still living in the area. The second
tracing exercise was at national level and was
undertaken in 1999. The information and statistics
division (ISD) of the NHS in Scotland, Edinburgh, used
probability matching to identify any women from the
cohort who were admitted to hospital from 1980 to
1999. In collaboration with the NHS central registry in
Southport, the division also ascertained the vital status
of women in the cohort and obtained death certificates
for any who had died, including those who died in the
United Kingdom but outside Scotland. We retrieved
the original databank records of women who could not
be traced through either exercise to check whether
additional information was available to maximise trac-
ing rates.
Ascertainment of outcomes
Questionnaire and clinical examination—We contacted
the general practitioner of each woman still living in
Grampian and sought consent for us to contact her.We
sent those for whom consent was given a self comple-
tion questionnaire, with questions covering general
health, lifestyle and wellbeing, and obstetric history,
including illnesses related to pregnancy. The questions
were taken from previously validated questionnaires.
The study hypothesis was not disclosed to prevent bias
in reporting current health status. Non-respondents
received two reminder questionnaires together with
reply paid envelopes. The questionnaire included an
invitation to contribute further by attending for a
medical examination. Each medical examination was
conducted by one of two trained research nurses in
accordance with an examination protocol developed
for the project. The nurses were blind to study group
status of the women they were examining, and
appointments were scheduled in a random manner so
that no batching of groups occurred, which would
undermine blinding. All women had blood pressure
measured twice with a random zero sphygmomanom-
eter with the appropriate cuff size in the seated
position after a period of rest, and the mean of the two
readings was taken. Height and weight were measured
and an electrocardiogram produced.
Hospital discharges—In collaboration with the infor-
mation and statistics division (ISD) of the NHS in Scot-
land we conducted a data linkage exercise25 to obtain
details of all hospital discharges in cohort members.
The division holds data on hospital discharges and
cancer registrations of individuals who have been resi-
dent in Scotland at any point. Probability matching was
based on first name, surname, previous surname, and
date of birth, and any obvious mismatches were
checked manually by the division.
Deaths—We obtained details of the dates and causes
of death from the UK NHS central register.
Sample size
The expected frequency of outcome measures varies
for different cardiovascular conditions in women in
Scotland, from 0.5% for electrocardiographic evidence
of myocardial infarction to over 8% for angina defined
by Rose questionnaire criteria.3 The frequency of
hypertension varies depending on the definition used.
One study of women aged 40-59 years in Scotland
identified 7% with a diastolic pressure greater than 100
mm Hg.26 For an outcome present in 5% of the control
group, a sample size of 932 subjects per group would
detect a doubling of risk, with 80% power at the 5%
level of significance. On this basis, we included all
women with pre-eclampsia or eclampsia (likely to be
the group with fewest potential members) in the
cohort and randomly sampled control and gestational
hypertension groups (matched for age and year of
delivery) of the same size as this group.
Statistical analysis
We used 2 and t tests as appropriate to test for baseline
differences between the three groups, and, for all
analyses, we used the control group as reference for
comparisons with each of the two “exposed” groups
(gestational hypertension and pre-eclampsia or
eclampsia). For the questionnaire and clinical examina-
tion data, we computed odds ratios and used logistic
regression methods to adjust for the influences of age,
body mass index, and smoking behaviour at follow up.
For the mortality and hospital discharge outcomes, we
constructed diagnosis groups using international
classification of diseases (ninth/tenth edition) codes:
“hypertension” (401-4/I10-14); “ischaemic heart
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disease” (410-4, 428/I20-25, I50); “cerebrovascular dis-
ease” (430-8/I60-9); “kidney disease” (580-99/N00-
39); “other circulatory disease” (390-8, 405, 415-27,
440-59/ I00-9, I15, I26-8, I30-49, I51-2, I70-99). We
counted only first admissions in a diagnosis group,
using the date of first admission as the incident date,
but women could appear in more than one diagnosis
group.We computed incident rate ratios for deaths and
hospital discharges and used logistic regression to
adjust for potential confounders.
Social class (UK registrar general) at time of follow
up was used for analyses of questionnaire and clinical
examination outcomes. This was allocated on the basis
of the woman’s own social class, unless this fell outside
classes I-V, in which case the spouse or partner’s social
class was used if available. Social class at the time of the
index pregnancy, based on the occupation of the
spouse or head of household, was used for analyses of
hospital admissions and deaths.
Results
The total cohort comprised 3593. Table 1 summarises
the baseline characteristics of the three groups. The
similarity of the mean ages at delivery reflects the
initial age matching. Compared with the control
group, women in the gestational hypertension and
pre-eclampsia or eclampsia groups were less likely to
be in occupational classes I-III non-manual
(professional/administrative) but more likely to have
booked for antenatal care before 20 weeks’ gestation.
They were also less likely to ever have been smokers
Original sample (n=3593)
Control =1197
Gestational hypertension = 1197
Pre-eclampsia/eclampsia = 1199
Presumed living elsewhere, died,
unknown (n=1630)
Control = 708
Gestational hypertension = 545
Pre-eclampsia/eclampsia = 377
Identified from local community
health index as living in Grampian
(n=1963)
Control = 489
Gestational hypertension = 652
Pre-eclampsia/eclampsia = 822
Some vital status information
 from questionnaire, Scottish
morbidity records, or death records
(n=2790)
Control = 796
Gestational hypertension = 951
Pre-eclampsia/eclampsia = 1043
Local tracing exercise in 1996 National tracing exercise in 1999
Vital status not known by
any method (n=803)
Control = 401
Gestational hypertension = 246
Pre-eclampsia/eclampsia = 156
Consent not obtained
(n=87)
Control = 24
Gestational hypertension = 20
Pre-eclampsia/eclampsia = 43
Consent obtained,
questionnaire sent
(n=1876)
Control = 465
Gestational hypertension = 632
Pre-eclampsia/eclampsia = 779
Hospital discharge morbidity data
recorded by  Scottish morbidity
records by end of 1997
(n=1829)
Control = 513
Gestational hypertension = 599
Pre-eclampsia/eclampsia = 717
Deaths from NHS central register,
general register office, or Scottish
morbidity records by end of 1997
(n=265)
Control = 72
Gestational hypertension = 89
Pre-eclampsia/eclampsia = 104
Declined examination
(n=320)
Control = 89
Gestational hypertension = 102
Pre-eclampsia/eclampsia = 129
Attended for examination
(n=992)
Control = 206
Gestational hypertension = 343
Pre-eclampsia/eclampsia = 443
Non-response or questionnaire
returned blank
(n=523)
Control = 158
Gestational hypertension = 174
Pre-eclampsia/eclampsia = 191
Correct identity,
questionnaire returned 
(n=1312)
Control = 295
Gestational hypertension = 445
Pre-eclampsia/eclampsia = 572
Completed by
incorrect person
(n=41)
Control = 12
Gestational hypertension = 13
Pre-eclampsia/eclampsia = 16
Fig 1 Cohort tracing in two different exercises including events up to 1997 (death and hospital discharge frequencies are not mutually
exclusive; many women who died also had hospital discharges)
Table 1 Baseline characteristics of study cohort at booking unless stated otherwise
Group
Control Gestational hypertension Pre-eclampsia/eclampsia
Total 1197 1197 1199
Mean (SD) age at delivery (years) 24.2 (4.69) 24.2 (4.64) 24.2 (4.68)
No (%) ≤ 20 weeks’ gestation 736/1007 (73.1) 908/1155 (78.6)† 935/1140 (82.0)†
Mean (SD) BMI (kg/m2)* 21.3 (2.7) 22.3 (3.1)† 22.2 (3.1)†
No (%) in social class I-III non-manual 384/947 (40.6) 370/1130 (32.8)† 291/1084 (26.8)†
No (%) who had ever smoked 140/325 (43.0) 124/349 (35.5)† 118/346 (34.1)†
*Corrected for gestation, excludes women over 20 weeks’ gestation at booking; data missing for 10 women.
†P<0.05 compared with control group.
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(although smoking data at the time of pregnancy were
incomplete), and there were small significant differ-
ences between the groups in mean body mass index.
Tracing
Local tracing identified 1963 women (54.6%) who were
still alive and resident in Grampian (figure). General
practitioners gave consent for a questionnaire to be
sent to 1876 (95.6%) of these women. The information
and statistics division ascertained the current vital
status of 2790 (77.7%) of the original cohort, of whom
265 (9.5%) were known to have died. Linkage with hos-
pital discharge data identified 1829 (65.6%) women of
the original cohort who had been admitted at least
once to a Scottish hospital between 1980 and 1999.
Compared with these untraced women, on average the
traced women were a year older at delivery, the mean
body mass index at the time of the index pregnancy
was 0.6 kg/m2 higher, and fewer were from
non-manual social classes (31% (778/2481) v 39%
(267/680)). The success of the tracing differed across
the three comparison groups (figure).
Of the 1876 questionnaires, 1312 (71%) were
returned with usable responses. Forty one were incor-
rectly identified as being eligible for the study by the
Aberdeen neonatal and maternity databank. Table 2
summarises the self reported demographic and health
characteristics of the questionnaire respondents at
follow up. Respondents were more likely to be in
manual social classes at baseline than the starting
cohort. Respondents in gestational hypertension and
pre-eclampsia or eclampsia groups had higher mean
body mass index at follow up and were less likely to be
former or current smokers, as they were at baseline.
There were no clinically significant differences in alco-
hol intake, regular exercise, or use of exogenous
hormones across the groups. A much higher
proportion of the women were of non-manual social
classes at follow up, using the woman’s own profession,
Table 2 Baseline and follow up characteristics of questionnaire respondents. Figures are numbers (percentage) of women unless
stated otherwise
Group
Control Gestational hypertension Pre-eclampsia/eclampsia
Total respondents 295/453 (65.1) 445/619 (71.9) 572/763 (75.0)
Attended for clinical examination 206 (69.8) 343 (77.1) 443 (77.4)
Mean (SD) age (years) 59.9 (8.0) 60.7 (7.5) 60.4 (7.6)
≤20 weeks’ gestation at booking 183/253 (72.3) 348/430 (80.9)‡ 472/548 (86.1)‡
In social class I-III non-manual at follow up 181/287 (63.0) 279/437 (63.8) 350/562 (63.3)
Attained higher education 109/293 (37.2) 134/438 (30.2) 173/563 (30.5)
Mean (SD) BMI at follow up (kg/m2)* 25.4 (4.5) 26.6 (4.7)§ 26.9 (4.8)§
Alcohol intake (units/week):
0 146 (49.5) 233 (52.4) 303 (53.0)
1-14 139 (47.1) 199 (44.7) 258 (45.1)
>14 10 (3.4) 13 (2.9) 11 (1.9)
Took regular exercise† 80/286 (28.2) 109/427 (25.5) 176/556 (31.7)
Had ever smoked at follow up 158/295 (53.6) 210/445 (47.2)‡ 227/572 (39.7)‡
Ever used oral contraceptive 128/294 (43.5) 172/438 (39.3) 240/563 (42.6)
Ever used hormone replacement therapy 95/291 (32.6) 115/436 (26.4) 154/562 (27.4)
*Data missing for five respondents.
†≥20 minutes ≥ three times per week.
‡P<0.05 compared with control group.
Table 3 Odds ratios (control group=1.0) for measures of hypertensive and other cardiovascular disease in questionnaire respondents
Outcome Control*
Gestational hypertension Pre-eclampsia/eclampsia
No*
Odds ratio
(unadjusted)
Adjusted† odds
ratio (95% CI) P value No*
Odds ratio
(unadjusted)
Adjusted† odds
ratio (95% CI) P value
Hypertension, doctor
diagnosis
76/277 215/428 2.67 2.47 (1.74 to, 3.51) <0.001 327/542 3.02 3.98 (2.82 to 5.61) <0.001
Currently taking
anti-hypertensive
medication
43/295 113/442 2.01 1.89 (1.23 to 2.88) 0.003 151/565 2.14 1.90 (1.27 to 2.86) 0.002
Stroke, doctor
diagnosis
3/266 10/404 2.23 2.42 (0.59 to 9.98) 0.22 19/511 3.39 3.41 (0.95 to 12.2) 0.06
Angina, doctor
diagnosis
24/273 40/413 1.11 1.02 (0.58 to 1.81) 0.94 69/518 1.59 1.61 (0.95 to 2.73) 0.08
Angina, Rose criteria 22/290 34/441 1.02 0.93 (0.52 to 1.65) 0.80 47/559 1.12 0.90 (0.52 to 1.55) 0.69
Possible MI, doctor
diagnosis
14/268 16/408 0.74 0.73 (0.32 to 1.63) 0.44 20/512 0.74 0.76 (0.35 to 1.63) 0.48
Possible MI, Rose
questionnaire
22/292 19/444 0.55 0.48 (0.25 to 0.95) 0.03 36/569 0.83 0.84 (0.47 to 1.50) 0.56
Intermittent
claudication, Rose
criteria
3/292 7/440 1.56 1.54 (0.38 to 6.19) 0.55 9/565 1.56 1.57 (0.41 to 6.05) 0.51
DVT, doctor diagnosis 22/269 25/404 0.74 0.65 (0.35 to 1.20) 0.17 33/510 0.78 0.75 (0.42 to 1.34) 0.32
“Kidney disease”,
doctor diagnosis
7/267 9/398 0.85 0.64 (0.22 to 1.82) 0.40 28/508 2.17 2.39 (1.01 to 5.65) 0.05
MI=myocardial infarction; DVT=deep vein thrombosis.
*Denominator excludes missing responses.
†Adjusted for age, BMI, social class, and smoking habit.
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than at baseline using husband/partner’s profession.
There was no gradient in social class at follow up
across the groups using this measure.
Questionnaire assessed outcomes
After adjustment for known risk factors for hyper-
tension, women in both the gestational hypertension
and pre-eclampsia or eclampsia groups had higher
odds ratios for indicators of hypertension (table 3).
This was not seen for the other conditions of interest,
except for kidney disease in the pre-eclampsia or
eclampsia group, which may have related to the origi-
nal episode in pregnancy. Similar results were observed
in the clinical examination data (table 4), with
increased risk of hypertension defined by WHO crite-
ria in both gestational hypertension and pre-eclampsia
or eclampsia groups. In total, 41.1% of the former and
48.8% of the latter provisionally fulfilled the WHO cri-
teria for hypertension compared with 26.7% in the
control group.
Hospital admissions
Women in the gestational hypertension group were
more likely to have been admitted to hospital for
cerebrovascular disease, ischaemic heart disease,
hypertension, and “other” circulatory disease, although
this reached significance only for hypertension and
other circulatory disease (table 5). Women in the
pre-eclampsia or eclampsia group were also more
likely to be admitted for hypertension, cerebrovascular
disease, and other circulatory disease.
Mortality
Over 90% of the traced cohort were alive at the time of
analysis, and there were 265 deaths available for analy-
sis (table 6). By the time of follow up, there were 72
deaths in the control group, 89 in the gestational
hypertension group, and 104 in the pre-eclampsia or
eclampsia group. No deaths were coded to hyper-
tension per se. After adjustment, mortality for all
causes, stroke, and ischaemic heart disease was higher
Table 4 Odds ratios (control group=1.0) for measures of hypertensive and other cardiovascular disease at clinical examination
Control
Gestational hypertension Pre-eclampsia/eclampsia
No
Odds ratio
(unadjusted)
Adjusted* odds ratio
(95% CI) P value No
Odds ratio
(unadjusted)
Adjusted* odds ratio
(95% CI) P value
Currently taking
anti-hypertensive
drugs
25/206 80/343 2.20 1.95 (1.18 to 3.24) 0.009 129/443 2.97 2.77 (1.72 to 4.47) <0.001
Not on
anti-hypertensive
drugs but raised
blood pressure at
time of
examination†
30/206 61/343 1.26 1.13 (0.69 to 1.86) 0.63 87/443 1.43 1.40 (0.87 to 2.26) 0.16
Provisionally fulfilling
WHO criteria for
hypertension
55/206 141/
343
1.90 1.70 (1.13 to 2.56) 0.01 216/443 2.60 2.62 (1.77 to 3.86) <0.001
Changes on ECG (any
abnormality)‡
20/205 32/342 0.95 0.96 (0.52 to 1.77) 0.90 61/437 1.50 1.96 (0.96 to 2.98) 0.07
*Adjusted for age, BMI, social class, and smoking habit.
†Mean diastolic ≥95 mm Hg or mean systolic ≥ 160 mm Hg or both.
‡Minnesota coding.
Table 5 Incident rate ratios (control group=1.0) for hospital admissions for specific conditions for all traced women
Discharge
diagnosis*
Admissions in
control group
(n=796)
Gestational hypertension (n=951) Pre-eclampsia/eclampsia (n=1043)
No of
admissions
Incident rate
ratio
(unadjusted)
Adjusted† incident
rate ratio (95% CI)
P
value
No of
admissions
Incident rate
ratio
(unadjusted)
Adjusted† incident
rate ratio (95% CI)
P
value
All causes 513 599 0.97 0.96 (0.84 to 1.09) 0.53 717 1.09 1.07 (0.95 to 1.22) 0.28
Hypertension 7 28 3.36 3.72 (1.43 to 9.65) 0.007 31 3.39 3.19 (1.21 to 8.39) 0.019
Cerebrovascular
disease
13 22 1.42 1.53 (0.72 to 3.27) 0.27 34 2.00 2.10 (1.02 to 4.32) 0.043
Ischaemic heart
disease
38 52 1.15 1.06 (0.68 to 1.65) 0.79 48 0.96 0.89 (0.56 to 1.40) 0.61
Other circulatory 64 108 1.42 1.51 (1.06 to 2.14) 0.021 121 1.45 1.49 (1.05 to 2.11) 0.024
Kidney disease 38 34 0.75 0.76 (0.47 to 1.28) 0.29 67 1.35 1.27 (0.81 to 1.98) 0.30
*First admission only for diagnosis group.
†Adjusted for age at delivery and social class.
Table 6 Incident rate ratios (control group=1.0) for mortality for specific conditions all traced women
Cause
Deaths in
control group
(n=796)
Gestational hypertension (n=951) Pre-eclampsia/eclampsia (n=1043)
Deaths
Incident rate
ratio
(unadjusted)
Adjusted* incident
rate ratio (95% CI) P value Deaths
Incident rate
ratio
(unadjusted)
Adjusted† incident
rate ratio (95% CI) P value
All causes 72 89 1.03 1.03 (0.74 to 1.45) 0.85 104 1.13 1.17 (0.84 to 1.65) 0.36
Cerebrovascular
disease
5 13 2.18 2.87 (0.81 to 10.2) 0.10 16 2.44 3.59 (1.04 to 12.4) 0.044
Ischaemic heart
disease
10 17 1.42 1.21 (0.53 to 2.75) 0.65 26 1.98 1.95 (0.90 to 4.21) 0.091
*Adjusted for age at delivery and social class.
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in both the gestational hypertension and pre-
eclampsia or eclampsia groups. The pattern was
consistent, though only the increased risk of stroke in
the pre-eclampsia or eclampsia group was significant.
Discussion
Women with a history of gestational hypertension or of
pre-eclampsia or eclampsia are at increased risk of
hypertensive and associated diseases in later life. Our
findings are consistent with those of previous work.7–15
We found an increased risk of admission to hospital for
stroke and mortality from stroke but no significant
increased risk of morbidity and mortality from coron-
ary heart disease as has previously been reported.16 17
This may be because we used a study design that did
not depend on recall and used standardised criteria to
distinguish gestational hypertension and pre-
eclampsia from chronic pre-existing hypertension.
This is of importance in counselling women about
their future health risks after delivery and in designing
healthcare interventions to minimise avoidable mor-
bidity and mortality.
Our design minimised the information bias that
may occur with retrospective studies and quantified the
absolute risk of adverse outcomes. It has two key
advantages over many other investigations into the
associations of interest: the underlying cohort design
and the use of different data sources to ascertain the
outcomes of interest, which permitted assessment of
the consistency of the findings.
Influence of social class
Social class differed between the three study groups in
the original cohort. This might be a result of chance or
might indicate an association between social class and
hypertensive diseases in pregnancy. Though such asso-
ciations have been reported,27 28 there is no clear social
class gradient. Pre-eclampsia or eclampsia is less com-
mon in smokers than in non-smokers27 28 and currently
smoking is associated with social class, though in 1961
UK survey data showed little social class gradient in
smoking in women.29 We found a modest gradient in
smoking across social class at the time of pregnancy
but smoking information was recorded for only 28%. If
there is a true inverse association between pre-
eclampsia or eclampsia and smoking, and if recorded
smoking habit during first pregnancy is an indicator of
likely smoking habit in later life, then the pre-eclampsia
or eclampsia group should in theory be at a lower than
average risk of smoking related disease in later life. If
so, this would operate against the hypothesis and might
suggest that our results underestimate the association
between pre-eclampsia or eclampsia and circulatory
diseases.
Several studies have shown a risk of coronary heart
disease associated with pre-eclampsia, though our
findings were not significant. Retrospective studies of
coronary heart disease that used patient recall of
pre-eclampsia are subject to recall bias, while other
cohort studies have combined coronary heart disease
outcomes into a single cardiovascular disease group.30
Tracing and investigation
The tracing rates varied across the three groups. Those
who were normotensive during their first full term
pregnancy were least likely to still be living in
Grampian at follow up, suggesting selective migration
from the area by the control groups. The national trac-
ing exercise, however, was more successful and
provided vital status and hospital discharge data for a
larger proportion of women in each comparison
group. Broadly similar patterns of cardiovascular
sequelae were observed in the different groups,
irrespective of whether the outcome measure used was
obtained through the local or national tracing.
Another important potential bias could have occurred
if there were important differences in the response
rates of those traced locally. There were in fact only
small differences in the response rates to the survey by
the three comparison groups (70%, 77%, and 77%) as
shown in table 2, suggesting that response bias is
unlikely to have materially affected our results. There
were more women from higher social classes in the
control group (table 1). Such women were more likely
to emigrate from Grampian, resulting in a lower
response rate in the control group.
Consistency of findings
There was consistency of the findings across the differ-
ent methods of ascertaining outcomes. The association
between gestational hypertensive disease and hyper-
tension in later life was seen in the questionnaire and
clinical examination data and also in the hospital diag-
nosis data and the mortality data. We suggest that our
observations cannot be explained by chance or bias.
The findings have implications for the aetiology and
pathogenesis of circulatory disease, both in pregnancy
and in later life. They also suggest that interventions
that might minimise the risk of such conditions in later
life should be identified and evaluated.
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Much is known about the effect of cardiovascular
risks factors that are shared by men and women,
but less on those specific to women
Retrospective studies, based on patient recall,
suggest that hypertension in pregnancy may be
associated with increased risk of cardiovascular
diseases in later life
What this study adds
Prospective recording of blood pressure and
proteinuria shows that women who experienced
raised blood pressure in pregnancy have a long
term risk of hypertension
Women who experience raise blood pressure in
pregnancy have an increased risk of stroke and, to
a lesser extent, an increased risk of ischaemic
heart disease
Long term cardiovascular risks are greater for
women who had pre-eclampsia than those who
experienced gestational hypertension
(hypertension without proteinuria)
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